[Plasminogen activator inhibitor (PAI-1) and markers of endothelial dysfunction in patients with diabetes mellitus]

Vnitr Lek. 1997 Nov;43(11):744-7.
[Article in Slovak]

Abstract

The authors examined 25 patients with diabetes mellitus type 2 (NIDDM) without vascular complications, treated by sulphonyl urea preparations, 12 hyperinsulinaemic (HI) non-diabetic subjects and 11 normoinsulinaemic healthy subject s. Patients with NIDDM and HI non-diabetics had significantly elevated PAI-1 levels which correlated with the C-peptide level (r = 0.519, p < 0.001), triacylglycerols (TG) (r = 0.685, p < 0.001), BMI (r = 0.607, p < 0.001) and levels of endothelial markers such as von Willebrand s factor and thrombomodulin (TM). In the group of patients with NIDDM no relationship of PAI-1 and C-peptide was found and a significant correlation was found with TM levels (r = 0.609, p = 0.001) and TG levels (r = 0.476, p = 0.046). The results suggest that the endothelial department has an effect on the regulation of PAI-1 levels in patients with NIDDM.

Publication types

  • English Abstract
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Diabetes Mellitus, Type 2 / blood*
  • Diabetes Mellitus, Type 2 / physiopathology
  • Endothelium, Vascular / physiopathology*
  • Humans
  • Hyperinsulinism / blood
  • Hyperinsulinism / physiopathology
  • Middle Aged
  • Plasminogen Activator Inhibitor 2 / blood*
  • Thrombomodulin / blood
  • Tissue Plasminogen Activator / blood
  • von Willebrand Factor / analysis

Substances

  • Plasminogen Activator Inhibitor 2
  • Thrombomodulin
  • von Willebrand Factor
  • Tissue Plasminogen Activator